Astragalus and other 10 kinds of traditional Chinese medicine will become the leading role in the industry

Business news on October 25 On October 24, the Provincial Department of Agriculture issued the development plan of Shanxi Provincial Traditional Chinese medicine industry (discussion draft) Relying on the advantages of traditional Chinese medicine varieties and the characteristics of rich wild resources and large mountain area, our province will focus on the development of 10 key varieties of Astragalus, dangshen, Scutellaria, forsythia, Polygala, rehmannia, yam, bupleurum, winter flower and dogwood, as well as forsythia, seabuckthorn Wild tending of peach, apricot, wild sour jujube, Polyporus, liquorice, Anemarrhena, Sophora flavescens and other varieties will strive to reach 4 million mu of standardized production area of traditional Chinese medicine in the whole province, with an annual output of 400 million kg and an annual output value of 5 billion yuan in three years The landform and ecological climate of our province are complex and diverse The planting area of traditional Chinese medicine is stable at about 1.3 million mu, accounting for 6.9% of the planting area of traditional Chinese medicine (in 2011, the planting area of traditional Chinese medicine was 18.63 million mu) Our province has initially established a complete industrial production system and circulation system of traditional Chinese medicine planting, processing, R & D and production of traditional Chinese medicine, and formed pharmaceutical industrial clusters with pharmaceutical industrial parks as the core, such as Datong, Taiyuan, Jinzhong, Houma, Yuncheng and Changzhi The compound Sophora flavescens injection, dingkundan, niuhuang'angong pill, Huangqi freeze-dried powder injection, weinaolutong, dinggui'er navel patch, and dashanhua pill produced by Shanxi kanglisheng Pharmaceutical Co., Ltd have become famous products in China The hawthorn leaf (fruit) extract (total flavonoids) produced by Shanxi kanglisheng Pharmaceutical Co., Ltd accounts for 90% of the market in China Although the industry of traditional Chinese medicine has made great progress in recent years, there are still some outstanding problems The leading enterprises of traditional Chinese medicine in our province are few and small in scale, which have limited pulling effect on the industry of traditional Chinese medicine At present, the annual processing volume of traditional Chinese medicine materials in the whole province is less than 20% of the annual output The annual sales revenue only accounts for 2% of the total sales revenue of the national traditional Chinese medicine industry, and the profit only accounts for 1% There are only two listed enterprises of TCM in our province, six in Shandong, six in Guangdong, five in Chongqing and four in Jilin The construction of TCM Market System in our province lags behind, so far there is no standardized, standardized and large-scale TCM wholesale and distribution market In addition, the province is short of technical personnel specialized in cultivation, breeding, processing and new drug research and development, and there are few professionals in the grass-roots technology promotion system Some experts predict that in the 21st century, botanical drugs will gradually become the mainstream of the global pharmaceutical market, and the demand for Chinese herbal medicines will grow rapidly in various countries The market share of international botanical drugs has reached 40 billion US dollars every year Most of the counties in our province belong to mountainous and hilly areas These areas are excellent areas for many genuine Chinese herbal medicines, and the benefit of planting Chinese herbal medicines is very considerable It is estimated that the average income per mu is about 3000 yuan Last year, the income of Scutellaria, Yuanzhi, Chaihu and ludongshen was more than 5000 yuan per mu, with the highest of 16000 yuan per mu In the next few years, our province will implement the "2134" Chinese herbal medicine industry development project That is, to establish 20 base counties of traditional Chinese medicine superior varieties, such as Astragalus, Scutellaria, dangshen, bupleurum, Yuanzhi, rehmannia and forsythia, to support 100 professional cooperatives of traditional Chinese medicine with strong demonstration and standardized operation, to support 30 leading enterprises of traditional Chinese medicine with an annual output value of more than 50 million yuan, to be listed in the "513" project of agricultural industrialization in our province, and to build 4 million mu of genuine Chinese medicine The standardized production base of traditional Chinese medicine will build our province into a first-class national modern industrial base of traditional Chinese medicine.